Author Question: Legionella pneumophila and Francisella tularensis share the characteristic of A) being easily ... (Read 88 times)

melina_rosy

  • Hero Member
  • *****
  • Posts: 531
Legionella pneumophila and Francisella tularensis share the characteristic of
 
  A) being easily identified by biochemical testing.
  B) having an animal reservoir.
  C) a requirement for cysteine to grow in culture.
  D) the necessity for the use of Gimenez stain rather than Gram stain to visualize.

Question 2

Which of the following is responsible for the waterproof skin barrier that is also effective against microorganisms?
 
  A) Merkel discs B) Horny solehorn C) Melanin D) Keratin



mjenn52

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

C

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

mjenn52

  • Sr. Member
  • ****
  • Posts: 351

 

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

Glaucoma is a leading cause of blindness. As of yet, there is no cure. Everyone is at risk, and there may be no warning signs. It is six to eight times more common in African Americans than in whites. The best and most effective way to detect glaucoma is to receive a dilated eye examination.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library